We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
The rapid progress in COVID vaccine development and implementation.
- Authors
Barrett, Alan D. T.; Titball, Richard W.; MacAry, Paul A.; Rupp, Richard E.; von Messling, Veronika; Walker, David H.; Fanget, Nicolas V. J.
- Abstract
Although vaccines depend on the native S-protein for inducing potent neutralizing antibody responses alongside T-cell responses, the presentation of the S-protein to the immune system differs substantially between the different vaccine platform technologies[11]. Not surprisingly, the different vaccines varied in their abilities to induce antibodies (including neutralizing antibodies), T-cell responses, and their reactogenicity and efficacy. Following the authorization or licensing of a vaccine, implementation becomes the critical issue, especially with respect to vaccine hesitancy. January 2022 is the second anniversary of the identification of Coronavirus disease 2019 (COVID-19)[1] caused by severe acute respiratory syndrome (SARS) coronavirus 2 (SARS-CoV-2).
- Subjects
COVID-19; COVID-19 vaccines; VACCINE development
- Publication
NPJ Vaccines, 2022, Vol 7, Issue 1, p1
- ISSN
2059-0105
- Publication type
Editorial
- DOI
10.1038/s41541-022-00442-8